These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 1308900)

  • 1. [Comparative urinary elimination of caffeine in sedentary and sportsmen after administration of Guronsan].
    Chauvel V; Divet D; Dassonville J; Rochcongar P; Anger JP
    J Toxicol Clin Exp; 1992 Dec; 12(8):503-12. PubMed ID: 1308900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine and sport: role of physical exercise upon elimination.
    Duthel JM; Vallon JJ; Martin G; Ferret JM; Mathieu R; Videman R
    Med Sci Sports Exerc; 1991 Aug; 23(8):980-5. PubMed ID: 1956275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of caffeine in urine and saliva of horses subjected to urinary acidification.
    Carregaro AB; Mataqueiro MI; Soares OA; Queiroz-Neto A
    J Appl Toxicol; 2004; 24(6):513-8. PubMed ID: 15551384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine: use and abuse in sports.
    Delbeke FT; Debackere M
    Int J Sports Med; 1984 Aug; 5(4):179-82. PubMed ID: 6480201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of the effect of fasting during Ramadan on the glycaemia at rest in sportsmen and sedentaries].
    Ba A; Samb A; Seck D; Kane MO; Seck MB; Sarr FB; Ciss M; Gueye L; Cisse F
    Dakar Med; 2005; 50(1):22-5. PubMed ID: 16190121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ad libitum ingestion of a caffeinated carbohydrate-electrolyte solution on urinary caffeine concentration after 4 hours of endurance exercise.
    Kovacs EM; Martin AM; Brouns F
    Int J Sports Med; 2002 May; 23(4):237-41. PubMed ID: 12015622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of single doses of rufloxacin on the disposition of theophylline and caffeine after single administration.
    Cesana M; Broccali G; Imbimbo BP; Crema A
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):133-8. PubMed ID: 2071262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creatine and caffeine in anaerobic and aerobic exercise: effects on physical performance and pharmacokinetic considerations.
    Vanakoski J; Kosunen V; Meririnne E; Seppälä T
    Int J Clin Pharmacol Ther; 1998 May; 36(5):258-62. PubMed ID: 9629989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements.
    Tang BK; Zhou Y; Kadar D; Kalow W
    Pharmacogenetics; 1994 Jun; 4(3):117-24. PubMed ID: 7920691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of caffeine levels in urine in different sports in relation to doping control before and after the removal of caffeine from the WADA doping list.
    Van Thuyne W; Delbeke FT
    Int J Sports Med; 2006 Sep; 27(9):745-50. PubMed ID: 16586337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of caffeine levels in urine in different sports in relation to doping control.
    Van Thuyne W; Roels K; Delbeke FT
    Int J Sports Med; 2005 Nov; 26(9):714-8. PubMed ID: 16237615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of caffeine in lactating dairy cows.
    DeGraves FJ; Ruffin DC; Duran SH; Spano JS; Whatley EM; Schumacher J; Riddell MG
    Am J Vet Res; 1995 May; 56(5):619-22. PubMed ID: 7661457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine clearance in patients with hepatocellular carcinoma after transcatheter oily chemoembolization treatment.
    Thong-Ngam D; Thumvijit L; Tangkijvanich P; Janchai A; Mahachai V; Wittayalertpanya S
    J Med Assoc Thai; 2002 Dec; 85(12):1280-7. PubMed ID: 12678165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of nitric oxide metabolites in runners, sedentary individuals and patients with coronary artery disease: effects of 42 km marathon, 15 km race and a cardiac rehabilitation program.
    Rodriguez-Plaza LG; Alfieri AB; Cubeddu LX
    J Cardiovasc Risk; 1997; 4(5-6):367-72. PubMed ID: 9865669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of caffeine on prolonged intermittent-sprint ability in team-sport athletes.
    Schneiker KT; Bishop D; Dawson B; Hackett LP
    Med Sci Sports Exerc; 2006 Mar; 38(3):578-85. PubMed ID: 16540848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in pharmacokinetic and electroencephalographic responses to caffeine in sleep-sensitive and non-sensitive subjects.
    Bchir F; Dogui M; Ben Fradj R; Arnaud MJ; Saguem S
    C R Biol; 2006 Jul; 329(7):512-9. PubMed ID: 16797457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic aspects of caffeine in premature infants.
    De Carolis MP; Romagnoli C; Muzii U; Tortorolo G; Chiarotti M; De Giovanni N; Carnevale A
    Dev Pharmacol Ther; 1991; 16(3):117-22. PubMed ID: 1914785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary recovery of caffeine and its metabolites in healthy African children.
    Akinyinka OO; Sowunmi A; Honeywell R; Renwick AG
    Afr J Med Med Sci; 2001; 30(1-2):1-4. PubMed ID: 14510139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow.
    Sinués B; Sáenz MA; Lanuza J; Bernal ML; Fanlo A; Juste JL; Mayayo E
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):159-66. PubMed ID: 10067814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of the paraxanthine/caffeine ratio in the saliva of patients with liver cirrhosis].
    Perlík F; Pucelíková T; Slanar O
    Cas Lek Cesk; 2001 Feb; 140(2):51-3. PubMed ID: 11262908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.